PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Nov-2023 Global Cervical Spacer Systems Industry Set to Surge to US$ 744.2 Million by 2033 with a 6.9% CAGR, | Foreseen by FMI MARKITWIRED
17-Nov-2023 Global Atrial Appendage Occluder Industry Set to Reach US$ 8,193.0 Million by 2033 with a Striking 23.6% CAGR | FMI Insights MARKITWIRED
17-Nov-2023 Global 3D Surgical Microscope Systems Industry Aims for US$ 3,204.8 Million Valuation by 2033, Fueled by a 10.2% CAGR | Reveals by FMI MARKITWIRED
17-Nov-2023 Global Mammography Industry Set to Soar to US$ 4,899.7 Million by 2033 at a 10.1% CAGR | Insights by FMI MARKITWIRED
17-Nov-2023 CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers CluePoints
17-Nov-2023 NICE recommends empagliflozin (Jardiance®) for the treatment of adults with chronic kidney disease NICE
17-Nov-2023 Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene Health
17-Nov-2023 Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia Karuna Therapeutics
17-Nov-2023 Symbio & Dow Group Merges with Proinnovera to Form Leading Dermatology CRO, Symbio Proinnovera Symbio & Dow Group / Proinnovera
17-Nov-2023 Biofourmis and HealthXL Report: Digital Endpoint Support for Pharma Label Claims Expected to Become Common Before 2030 Biofourmis and HealthXL
17-Nov-2023 Contraceptive services to be expanded under Pharmacy First scheme, PAGB response The Department for Health and Social Care (DHSC)
17-Nov-2023 Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in cardiovascular disease, says GlobalData Verve Therapeutics
17-Nov-2023 ‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements UCB
17-Nov-2023 POLB 001 LPS Challenge Trial Data to be Presented at IUIS Poolbeg Pharma plc
17-Nov-2023 Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence Versameb AG
17-Nov-2023 Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX Minoryx
17-Nov-2023 Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards Amolyt Pharma
17-Nov-2023 Berry's PneumoHaler Enables Better Patient Administration and Speed-to-Market Berry Global Healthcare
17-Nov-2023 Researchers uncover role of ‘molecular plasters’ that protect against infection Francis Crick Institute
17-Nov-2023 Ori Biotech LEAPs forward toward commercialization in 2024 Ori Biotech